Euroopan unioni -
suomi -
EMA (European Medicines Agency)
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - muut hermoston huumeet - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - neuromuskulaarisen salpauksen aiheuttama rokuronin tai vekuronin. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
sugammadex aspen 100 mg/ml injektioneste, liuos
aspen pharma trading limited - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
sugammadex noridem 100 mg/ml injektioneste, liuos
noridem enterprises limited - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
sugammadex sandoz 100 mg/ml injektioneste, liuos
sandoz a/s - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulaarinen estäminen - sugammadeksi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulaarinen estäminen - kaikki muut terapeuttiset tuotteet - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
sugammadex hameln 100 mg/ml injektioneste, liuos
hameln pharma gmbh - sugammadex sodium - injektioneste, liuos - 100 mg/ml - sugammadeksi